Blossomhill Therapeutics, Inc.

BLSM

Financials

10-QQuarter ended 06/30/2609/18/26

Disclosures

8-KCurrent report09/18/268-KCurrent report09/15/268-KCurrent report08/10/26

Prospectuses and Registrations

S-8Registration of securities for employees08/10/26424B4Prospectus08/07/26S-1MEFProspectus / registration08/06/26S-1/ARegistration statement (amended)08/03/26S-1Registration statement (IPO)07/17/26

Proxies

No matching filings.

Ownership

SC 13DBeneficial ownership08/18/26SC 13GBeneficial ownership08/17/26SC 13GBeneficial ownership08/14/26SC 13DBeneficial ownership08/13/26Form 4Insider transaction08/12/26

Other

CERTCEO/CFO certification08/06/26EFFECTRequest for effectiveness08/06/268-A12B8-A12B08/04/26DRS/ADRS/A06/11/26DRSDRS04/24/26